Joseph C Presti

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi request reprint Lower body mass index is associated with a higher prostate cancer detection rate and less favorable pathological features in a biopsy population
    Joseph C Presti
    Department of Urology, Stanford University School of Medicine, Stanford, California 94305 5118, USA
    J Urol 171:2199-202. 2004
  2. ncbi request reprint Prostate biopsy strategies
    Joseph C Presti
    Stanford Cancer Center, Stanford, CA 94305 5826, USA
    Nat Clin Pract Urol 4:505-11. 2007
  3. ncbi request reprint Obesity and prostate cancer
    Joseph C Presti
    Division of Urologic Oncology, Department of Urology, Stanford University School of Medicine, Stanford, California 94305 5826, USA
    Curr Opin Urol 15:13-6. 2005
  4. ncbi request reprint Prostate biopsy: how many cores are enough?
    Joseph C Presti
    Department of Urology, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305 5118, USA
    Urol Oncol 21:135-40. 2003
  5. doi request reprint Repeat prostate biopsy--when, where, and how
    Joseph C Presti
    Department of Urology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Urol Oncol 27:312-4. 2009
  6. ncbi request reprint Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database
    Christopher R King
    Division of Urologic Oncology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305 5847, USA
    Urology 69:921-6. 2007
  7. ncbi request reprint Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database
    Stephen J Freedland
    Department of Urology, University of California, Los Angeles, School of Medicine, 90095 1738, USA
    Urology 61:742-7. 2003
  8. ncbi request reprint Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database
    Stephen J Freedland
    Department of Urology, University of California Los Angeles School of Medicine and Department of Surgery, Veterans Administration Greater Los Angeles Healthcare System, Los Angeles, California 90095, USA
    J Urol 169:2129-35. 2003
  9. ncbi request reprint Do younger men have better biochemical outcomes after radical prostatectomy?
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland 21287 2101, USA
    Urology 63:518-22. 2004
  10. ncbi request reprint Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database
    Stephen J Freedland
    Department of Urology, University of California Los Angeles, Department of Surgery, Veterans Affairs Greater Los Angeles Health Care System, Los Angeles, California 90095, USA
    J Urol 169:2136-41. 2003

Detail Information

Publications77

  1. ncbi request reprint Lower body mass index is associated with a higher prostate cancer detection rate and less favorable pathological features in a biopsy population
    Joseph C Presti
    Department of Urology, Stanford University School of Medicine, Stanford, California 94305 5118, USA
    J Urol 171:2199-202. 2004
    ..We assessed the relationship between BMI, and prostate cancer detection rates and biopsy features in a referral based biopsy population...
  2. ncbi request reprint Prostate biopsy strategies
    Joseph C Presti
    Stanford Cancer Center, Stanford, CA 94305 5826, USA
    Nat Clin Pract Urol 4:505-11. 2007
    ..This article reviews the history of prostate biopsy strategies with particular attention paid towards the development of extended biopsy schemes. Furthermore, a strategy is recommended for initial and repeat biopsy patients...
  3. ncbi request reprint Obesity and prostate cancer
    Joseph C Presti
    Division of Urologic Oncology, Department of Urology, Stanford University School of Medicine, Stanford, California 94305 5826, USA
    Curr Opin Urol 15:13-6. 2005
    ..This review provides an update on research into the association between obesity and prostate cancer...
  4. ncbi request reprint Prostate biopsy: how many cores are enough?
    Joseph C Presti
    Department of Urology, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305 5118, USA
    Urol Oncol 21:135-40. 2003
    ..We review several studies evaluating various biopsy schemes for both initial and repeat biopsy patients and propose an optimal biopsy scheme...
  5. doi request reprint Repeat prostate biopsy--when, where, and how
    Joseph C Presti
    Department of Urology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Urol Oncol 27:312-4. 2009
    ..In patients for whom repeat biopsies fail to identify cancer, yet the clinical suspicion remains high, consideration for a saturation biopsy approach seems warranted...
  6. ncbi request reprint Impact of obesity on the utility of preoperative prostate-specific antigen velocity to predict for relapse after prostatectomy: a report from the SEARCH database
    Christopher R King
    Division of Urologic Oncology, Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305 5847, USA
    Urology 69:921-6. 2007
    ....
  7. ncbi request reprint Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database
    Stephen J Freedland
    Department of Urology, University of California, Los Angeles, School of Medicine, 90095 1738, USA
    Urology 61:742-7. 2003
    ..We compared the total percentage of biopsy tissue with cancer to the percentage of cores positive for their ability to predict adverse pathologic findings and biochemical failure after radical prostatectomy (RP)...
  8. ncbi request reprint Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database
    Stephen J Freedland
    Department of Urology, University of California Los Angeles School of Medicine and Department of Surgery, Veterans Administration Greater Los Angeles Healthcare System, Los Angeles, California 90095, USA
    J Urol 169:2129-35. 2003
    ..We determined whether we could improve the prognostic value of the TNM staging system in men with cT1c and cT2 cancers by including information on whether prostate needle biopsy was unilaterally or bilaterally positive...
  9. ncbi request reprint Do younger men have better biochemical outcomes after radical prostatectomy?
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland 21287 2101, USA
    Urology 63:518-22. 2004
    ..Prior studies have suggested that younger men have lower prostate-specific antigen recurrence rates after RP, although none of the prior studies had controlled for the year of surgery...
  10. ncbi request reprint Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database
    Stephen J Freedland
    Department of Urology, University of California Los Angeles, Department of Surgery, Veterans Affairs Greater Los Angeles Health Care System, Los Angeles, California 90095, USA
    J Urol 169:2136-41. 2003
    ..We evaluate whether either percent of cores with cancer or percent of cores positive from the most and least involved side of the prostate needle biopsy was associated with a worse outcome among men treated with radical prostatectomy...
  11. ncbi request reprint Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database
    Stephen J Freedland
    Department of Urology, University of California, Los Angeles, School of Medicine, 90095 1738, USA
    Urology 61:736-41. 2003
    ..We also examined whether the biochemical recurrence rates after RP have changed with time...
  12. ncbi request reprint Should a positive surgical margin following radical prostatectomy be pathological stage T2 or T3? Results from the SEARCH database
    Stephen J Freedland
    Department of Urology, University of California Los Angeles and Department of Surgery, Veterans Affairs Greater Los Angeles Health Care System, Los Angeles, California 90095, USA
    J Urol 169:2142-6. 2003
    ..We examined the significance of the pathological features of positive surgical margin and extracapsular extension for predicting biochemical failure following radical prostatectomy...
  13. ncbi request reprint Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group
    Stephen J Freedland
    Department of Urology, The Johns Hopkins School of Medicine, 600 N Wolfe Street, Baltimore, MD 21287 2101, USA
    J Clin Oncol 22:446-53. 2004
    ..Given the limited information regarding the impact of obesity on treatment outcomes for prostate cancer, we sought to examine the relationship between body mass index (BMI) and cancer control after radical prostatectomy (RP)...
  14. ncbi request reprint Racial differences in prognostic value of adult height for biochemical progression following radical prostatectomy
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA
    Clin Cancer Res 11:7735-42. 2005
    ..However, hormonal activity and diets vary between races. We examined whether height was significantly associated with biochemical progression following radical prostatectomy and whether there was an interaction between height and race...
  15. ncbi request reprint Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland 21287, USA
    J Urol 171:2215-20. 2004
    ..We developed a preoperative model to risk stratify patients for prostate specific antigen (PSA) failure following radical prostatectomy (RP) and identify those at high risk who would be potential candidates for neoadjuvant clinical trials...
  16. ncbi request reprint Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy
    Matthew R Cooperberg
    Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, UCSF Comprehensive Cancer Center, University of California, San Francisco, California 94143, USA
    Cancer 107:2384-91. 2006
    ..This study used a large external dataset to validate CAPRA...
  17. ncbi request reprint Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD 21287 2101, USA
    J Urol 172:520-4. 2004
    ....
  18. doi request reprint Racial variations in the performance of prostate specific antigen and prostate specific antigen density in the era of extended prostate biopsy schemes
    Christopher S Elliott
    Department of Urology, Stanford University School of Medicine, California 94305 5118, USA
    J Urol 180:1318-23; discussion 1323-4. 2008
    ..We examined the performance of prostate specific antigen, prostate specific antigen density and transition zone density in racial groups undergoing an extended prostate biopsy scheme...
  19. ncbi request reprint The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEAR
    Stephen J Freedland
    Department of Urology, University of California Los Angeles, Los Angeles, California, USA
    Cancer 98:2344-50. 2003
    ....
  20. ncbi request reprint Biochemical outcome after radical prostatectomy among men with normal preoperative serum prostate-specific antigen levels
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland 21287 2101, USA
    Cancer 101:748-53. 2004
    ..Whether malignancies in such men are associated with better outcomes is unclear. The authors compared the risk of biochemical failure after radical prostatectomy (RP) between men with normal PSA levels and men with elevated PSA levels...
  21. ncbi request reprint Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base
    Stephen J Freedland
    Department of Urology, University of California Los Angeles School of Medicine, USA
    J Urol 169:969-73. 2003
    ..We determined whether preoperative PSA density calculated using transrectal ultrasound prostate volume was a better predictor of advanced pathological findings or biochemical recurrence after radical prostatectomy relative to PSA...
  22. ncbi request reprint Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: a search database study
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, 600 N Wolfe St, Baltimore, MD 21287 2101, USA
    J Clin Oncol 23:7546-54. 2005
    ..We examined whether prostate weight was associated with tumor grade, advanced disease, or risk of biochemical progression after radical prostatectomy (RP)...
  23. ncbi request reprint Predictors of prostate-specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland 21287, USA
    Cancer 100:1633-8. 2004
    ..The authors examined whether there was a subset of men with SV invasion who had long-term prostate-specific antigen (PSA) progression-free survival...
  24. ncbi request reprint Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCH
    Christopher R King
    Department of Radiation Oncology, Division of Urologic Oncology, Stanford University School of Medicine, Stanford, California 94305 5847, USA
    Urology 69:732-7. 2007
    ..We studied the timing, cutoff levels, and method of calculation to better define its usefulness...
  25. doi request reprint Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: analysis of the SEARCH database
    Steven L Chang
    Department of Urology, Stanford University Medical Center, Stanford, California 94305, USA
    Urology 75:439-44. 2010
    ..Previous studies demonstrate that a PSADT < 9 months after radical prostatectomy is associated with prostate cancer-specific mortality. Conventionally, PSADT has been calculated after biochemical failure (PSA > or = 2 0.2 ng/mL)...
  26. ncbi request reprint Positive family history of prostate cancer not associated with worse outcomes after radical prostatectomy
    Keith L Lee
    Division of Urologic Oncology, Department of Urology, Stanford University School of Medicine, Stanford, California 94305 5826, USA
    Urology 65:311-5. 2005
    ..To determine the clinical outcomes in men with (FH) and without (NFH) a family history of prostate cancer after radical prostatectomy...
  27. ncbi request reprint Preoperative PSA velocity is an independent prognostic factor for relapse after radical prostatectomy
    Deep A Patel
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305 5847, USA
    J Clin Oncol 23:6157-62. 2005
    ..We evaluated the relative merit of established preoperative factors, including biopsy indices and preoperative PSAV, for their impact on relapse after RP...
  28. ncbi request reprint Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
    J Urol 175:500-4; discussion 504. 2006
    ..We examined the association between BMI, and PSA and prostate weight in a cohort of men undergoing RP...
  29. ncbi request reprint Delay of radical prostatectomy and risk of biochemical progression in men with low risk prostate cancer
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
    J Urol 175:1298-302; discussion 1302-3. 2006
    ..Whether delays and especially prolonged delays, eg greater than 180 days, before RP negatively impact the disease outcome is unclear...
  30. doi request reprint The influence of prostate volume on prostate-specific antigen performance: implications for the prostate cancer prevention trial outcomes
    Christopher S Elliott
    Department of Urology, 300 Pasteur Drive, Stanford University Medical Center, Stanford, California 94305, USA
    Clin Cancer Res 15:4694-9. 2009
    ..This observation was driven by "for-cause" biopsies. We sought to understand how volume-dependent changes in prostate-specific antigen test performance characteristics may have contributed...
  31. doi request reprint The prostate cancer risk calculator from the Prostate Cancer Prevention Trial underestimates the risk of high grade cancer in contemporary referral patients
    Tin C Ngo
    Department of Urology, Stanford University School of Medicine, Stanford, California 94305, USA
    J Urol 185:483-7. 2011
    ..Since data used to create the calculator came from an unreferred population that underwent mainly sextant biopsy, to our knowledge its usefulness in the contemporary urology practice is unknown...
  32. doi request reprint Performance characteristics of prostate-specific antigen in patients undergoing radical prostatectomy
    Jen Jane Liu
    Department of Urology, Stanford University School of Medicine, Stanford, California 94305, USA
    Urology 79:1336-9. 2012
    ..It is known that the performance characteristics of PSA are improved for predicting the presence of high-grade prostate cancer...
  33. ncbi request reprint Postoperative prostate-specific antigen velocity independently predicts for failure of salvage radiotherapy after prostatectomy
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 70:1472-7. 2008
    ..Identification of patients most likely to benefit from salvage radiotherapy (RT) using postoperative (postop) prostate-specific antigen (PSA) kinetics...
  34. ncbi request reprint Impact of prior biopsy scheme on pathologic features of cancers detected on repeat biopsies
    Y Mark Hong
    Department of Urology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Urol Oncol 22:7-10. 2004
    ..Clinicopathologic features of cancers detected on repeat biopsy tend to be worse in patients who have undergone a prior negative sextant biopsy compared to a negative prior extended biopsy...
  35. ncbi request reprint Body mass index as a predictor of prostate cancer: development versus detection on biopsy
    Stephen J Freedland
    Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland 21287 2101, USA
    Urology 66:108-13. 2005
    ..To determine whether obesity is biologically associated with an increased risk of prostate cancer development, especially aggressive disease and to explore whether a bias may exist in our ability to detect these cancers in obese patients...
  36. ncbi request reprint Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients
    Christopher R King
    Division of Urologic Oncology, Department of Radiation, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 59:386-91. 2004
    ..This study examines the concordance patterns between biopsy and matched radical prostatectomy Gleason grade among patients undergoing an extended 10-core biopsy scheme to assess its reliability compared to sextant biopsies...
  37. doi request reprint Differing perceptions of quality of life in patients with prostate cancer and their doctors
    Geoffrey A Sonn
    Department of Urology, Stanford University, 300 Pastaur Drive, Stanford, CA 94305, USA
    J Urol 189:S59-65; discussion S65. 2013
    ..We determined if urologists have improved their reporting of patient health related quality of life. We also investigated if urologists assessed health related quality of life more accurately in the short or long term...
  38. doi request reprint Prostate size does not predict high grade cancer
    Tin C Ngo
    Department of Urology, Stanford University School of Medicine, Stanford, CA, USA
    J Urol 187:477-80. 2012
    ..In this study we analyzed this association in a more generalized population of men who underwent prostate needle biopsy...
  39. ncbi request reprint Reliability of small amounts of cancer in prostate biopsies to reveal pathologic grade
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305 5847, USA
    Urology 67:1229-34. 2006
    ..Prostate biopsy findings are known to undergrade prostate cancer compared with the pathologic specimens yet remain the only grade guiding disease management...
  40. ncbi request reprint Time trends in pathologic features of radical prostatectomy--impact of family history
    Jeffrey B Marotte
    Department of Urology, Division of Urologic Oncology, Stanford University School of Medicine, Stanford, CA 94305 5826, USA
    Urol Oncol 22:169-73. 2004
    ..8 vs. 7.9; P = 0.01) at the time of diagnosis. We believe these differences are predominantly driven by more aggressive screening in patients with a family history of prostate cancer rather than any true genetic differences...
  41. doi request reprint Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial
    Christopher R King
    Department of Radiation Oncology, Division of Urologic Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 73:1043-8. 2009
    ..The radiobiology of prostate cancer favors a hypofractionated dose regimen. We report results of a prospective Phase II clinical trial of stereotactic body radiotherapy (SBRT) for localized prostate cancer...
  42. doi request reprint Small prostate size and high grade disease--biology or artifact?
    Jen Jane Liu
    Department of Urology, Stanford University School of Medicine, Stanford, California 94305 5826, USA
    J Urol 185:2108-11. 2011
    ..We propose that this observation is the result of ascertainment bias driven by prostate specific antigen performance...
  43. ncbi request reprint Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database
    Stephen J Freedland
    Department of Urology, University of California, Los Angeles, School of Medicine, Los Angeles, California 90095 1738, USA
    Urology 60:670-4. 2002
    ....
  44. ncbi request reprint Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray
    John P T Higgins
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Am J Surg Pathol 31:673-80. 2007
    ..We conclude that the detection of S100P and GATA3 protein expression may help distinguish urothelial carcinomas from other genitourinary neoplasms that enter into the differential diagnosis...
  45. doi request reprint Smoking and adverse outcomes at radical prostatectomy
    Tin C Ngo
    Department of Urology, Stanford University School of Medicine, Stanford, CA 94305, USA Electronic address
    Urol Oncol 31:749-54. 2013
    ..In this series, we studied the effect of smoking on pathologic outcomes and biochemical recurrence in a cohort of men undergoing radical prostatectomy...
  46. doi request reprint Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series
    Pierre Nevoux
    Department of Urology, CHU Lille, Univ Lille Nord de France, Lille, France
    BJU Int 110:517-23. 2012
    ..One third of cancer foci were anteriorly located beyond the area sampled by posterior biopsies. One fifth of cancer foci were ≤ 6 mm of the apex...
  47. ncbi request reprint Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes?
    Christopher R King
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Int J Radiat Oncol Biol Phys 59:341-7. 2004
    ....
  48. ncbi request reprint Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study
    Joseph C Presti
    Department of Urology, Stanford University School of Medicine, Stanford, CA, USA
    J Urol 169:125-9. 2003
    ..We assessed the impact of age and prostate specific antigen (PSA) on extended systematic biopsy schemes for detecting prostate carcinoma and better characterized these tumors as a function of patient age and PSA...
  49. doi request reprint The performance of prostate specific antigen, prostate specific antigen density and transition zone density in the era of extended biopsy schemes
    Christopher S Elliott
    Department of Urology, Stanford University School of Medicine, Stanford, California, USA
    J Urol 179:1756-61; discussion 1761. 2008
    ..We defined the performance of these measures in a referral based population undergoing an extended prostate biopsy scheme...
  50. doi request reprint Plasmacytoid carcinoma of the bladder: a urothelial carcinoma variant with a predilection for intraperitoneal spread
    Roberto Rafael Ricardo-Gonzalez
    Department of Pathology, Stanford University Medical Center, Stanford, California 94305, USA
    J Urol 187:852-5. 2012
    ..Our experience suggests frequent intraperitoneal spread that is not typical of conventional urothelial carcinoma...
  51. ncbi request reprint Use of extended systematic sampling in patients with a prior negative prostate needle biopsy
    Chris H Chon
    Department of Urology, Stanford University School of Medicine, Stanford, California, USA
    J Urol 167:2457-60. 2002
    ..We examine the potential impact of extended systematic biopsy schemes in patients with a prior negative prostate biopsy...
  52. pmc Impact of common medications on serum total prostate-specific antigen levels: analysis of the National Health and Nutrition Examination Survey
    Steven L Chang
    Department of Urology, Stanford University School of Medicine, Stanford, CA 94305, USA
    J Clin Oncol 28:3951-7. 2010
    ..We investigated the impact of individual and combinations of common medications on PSA in a large cross-sectional study of the United States population...
  53. ncbi request reprint Gender differences in radical cystectomy: complications and blood loss
    Keith L Lee
    Department of Urology, Stanford University Medical Center, Stanford, California 94305 5118, USA
    Urology 63:1095-9. 2004
    ..Radical cystectomy is technically different between men and women. Unique to women, dissection of the anterior vaginal wall can be associated with added blood loss...
  54. ncbi request reprint The utility of apical anterior horn biopsies in prostate cancer detection
    Maxwell V Meng
    Department of Urology, University of California San Francisco, San Francisco, CA, USA
    Urol Oncol 21:361-5. 2003
    ..The use of these biopsies as part of an 8-core biopsy pattern provides high cancer detection in all groups of patients and may represent a new standard...
  55. ncbi request reprint Allelic loss on chromosomes 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney
    Joseph C Presti
    Department of Urology, Stanford University School of Medicine, Stanford, CA, USA
    J Urol 167:1464-8. 2002
    ..We correlated allelic loss on chromosomes 8p, 9p and 14q with clinical outcome in locally advanced conventional renal cell carcinoma...
  56. ncbi request reprint Laparoscopic radical nephrectomy incorporating intraoperative ultrasonography for renal cell carcinoma with renal vein tumor thrombus
    Thomas H S Hsu
    Section of Laparoscopic and Minimally Invasive Surgery, Division of Urologic Oncology, Department of Urology, Stanford University School of Medicine, California 94305 5118, USA
    Urology 61:1246-8. 2003
    ..Additional studies are necessary to evaluate its role in urologic oncologic surgery...
  57. doi request reprint Differing perceptions of quality of life in patients with prostate cancer and their doctors
    Geoffrey A Sonn
    Department of Urology, Stanford University, Stanford, California 94305 5118, USA
    J Urol 182:2296-302. 2009
    ..We determined if urologists have improved their reporting of patient health related quality of life. We also investigated if urologists assessed health related quality of life more accurately in the short or long term...
  58. ncbi request reprint Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database
    Robert J Hamilton
    Division of Urologic Surgery, Department of Surgery, Duke University School of Medicine, Durham, North Carolina 27710, USA
    Cancer 110:2202-9. 2007
    ..To address this issue, the authors examined racial differences in pathologic features, time to disease recurrence, and prostate-specific antigen (PSA) doubling time (PSADT) among a cohort of patients treated with RP...
  59. ncbi request reprint Body mass index, prostate weight and transrectal ultrasound prostate volume accuracy
    Kamran P Sajadi
    Augusta Veterans Affairs Medical Center and Medical College of Georgia, Augusta, Georgia 30912, USA
    J Urol 178:990-5. 2007
    ..We hypothesized that obesity may represent a technical challenge when performing transrectal ultrasound that decreases the accuracy of estimating prostate volume...
  60. ncbi request reprint Is a positive bladder neck margin truly a T4 lesion in the prostate specific antigen era? Results from the SEARCH Database
    W Cooper Buschemeyer
    Department of Surgery Division of Urologic Surgery, Duke University School of Medicine and Urology Section, Surgical Service, Veterans Affairs Medical Center Durham, Durham, North Carolina 27710, USA
    J Urol 179:124-9; discussion 129. 2008
    ..We examined the association between positive bladder neck margins and prostate specific antigen recurrence relative to other pathological findings...
  61. pmc Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications
    Stephen J Freedland
    Department of Surgery, Durham Veterans Affairs Medical Center, Durham, North Carolina, USA
    Urology 69:495-9. 2007
    ..Given the critical role that needle biopsy plays in treatment decisions, we sought to determine the risk factors for upgrading and downgrading the prostate biopsy specimen...
  62. ncbi request reprint Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score?
    Nicholas J Fitzsimons
    Division of Urologic Surgery, Duke Prostate Center, University Medical Center, Duke University School of Medicine, Durham, NC 27710, USA
    J Urol 176:2453-8; discussion 2458. 2006
    ..However, it is unclear whether it remains associated with outcome after surgery when the pathological Gleason score is known...
  63. ncbi request reprint Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10
    Patrick J Bastian
    James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Cancer 107:1265-72. 2006
    ....
  64. pmc Limitations of prostate specific antigen doubling time following biochemical recurrence after radical prostatectomy: results from the SEARCH database
    Robert J Hamilton
    Division of Urologic Surgery, Department of Surgery, Duke University School of Medicine, Durham, North Carolina 27710, USA
    J Urol 179:1785-9; discussion 1789-90. 2008
    ..Hence, those with calculable prostate specific antigen doubling time may represent a select lower risk group relative to all men with biochemical recurrence...
  65. pmc What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group
    Anna E Teeter
    Division of Urologic Surgery and Duke Prostate Center, Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Urol 180:1980-4; discussion 1985. 2008
    ..We determined which demographic and clinicopathological variables were predictive of a short prostate specific antigen doubling time in a cohort of men with clinically localized prostate cancer treated with radical prostatectomy...
  66. ncbi request reprint Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer
    Lionel L Banez
    Division of Urologic Surgery and the Duke Prostate Center, and Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    JAMA 298:2275-80. 2007
    ..Because men with higher body mass index (BMI) have greater circulating plasma volumes, lower PSA concentrations among obese men may be due to hemodilution...
  67. ncbi request reprint Small transrectal ultrasound volume predicts clinically significant Gleason score upgrading after radical prostatectomy: results from the SEARCH database
    Ryan S Turley
    Division of Urological Surgery, Duke Prostate Center, Duke University School of Medicine, Durham, North Carolina, USA
    J Urol 179:523-7; discussion 527-8. 2008
    ..We examined the likelihood of clinically relevant upgrading after radical prostatectomy as a function of transrectal ultrasound volume...
  68. doi request reprint The effect of race/ethnicity on the accuracy of the 2001 Partin Tables for predicting pathologic stage of localized prostate cancer
    Elisabeth I Heath
    Barbara Ann Karmanos Cancer Institute, Department of Hematology and Oncology, Wayne State University, 4100 John R, 4 HWCRC, Detroit, MI 48201, USA
    Urology 71:151-5. 2008
    ..To test the accuracy of the 2001 Partin Tables in African American men who underwent radical prostatectomy at multiple centers throughout the United States...
  69. ncbi request reprint PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database
    Stephen J Freedland
    Urology Section, Veterans Affairs Medical Center, Durham, NC, USA
    Eur Urol 53:758-64; discussion 765-6. 2008
    ..We examined the prognostic significance of preoperative PSA to predict pathologic stage and biochemical progression among men undergoing radical prostatectomy in the new millennium (2000-2006)...
  70. pmc Risk stratification for biochemical recurrence in men with positive surgical margins or extracapsular disease after radical prostatectomy: results from the SEARCH database
    Jayakrishnan Jayachandran
    Division of Urologic Surgery, Department of Surgery, Duke University School of Medicine, Durham, North Carolina 27710, USA
    J Urol 179:1791-6; discussion 1796. 2008
    ..We further stratified these men into a low risk group in which watchful waiting after surgery may be preferred and a high risk cohort in which adjuvant therapy may be preferred...
  71. ncbi request reprint Predicting unilateral prostate cancer based on biopsy features: implications for focal ablative therapy--results from the SEARCH database
    Charles D Scales
    Department of Surgery Division of Urologic Surgery, Duke University School of Medicine, Durham, North Carolina 27710, USA
    J Urol 178:1249-52. 2007
    ..However, few studies have assessed the correlation between biopsy parameters and pathological outcome (unilateral vs bilateral disease)...
  72. doi request reprint Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases
    Stephen J Freedland
    Urology Section, Department of Surgery, Veterans Affairs Medical Center, Duke University Medical Center, Durham, NC 27710, USA
    BJU Int 102:969-74. 2008
    ....
  73. pmc Obesity and positive surgical margins by anatomic location after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database
    Jayakrishnan Jayachandran
    Urology Section, Veterans Affairs Medical Center, Duke University School of Medicine, Durham, NC 27710, USA
    BJU Int 102:964-8. 2008
    ....
  74. pmc Risk stratification of men with Gleason score 7 to 10 tumors by primary and secondary Gleason score: results from the SEARCH database
    David E Kang
    Division of Urologic Surgery, Department of Surgery and Duke Prostate Center, Duke University School of Medicine, Durham, North Carolina, USA
    Urology 70:277-82. 2007
    ..Whether the increased risk associated with Gleason score 4+3 disease is equivalent to that of Gleason score 4+4 or greater is unclear...
  75. ncbi request reprint Changing nature of high risk patients undergoing radical prostatectomy
    Christopher J Kane
    Urology Section, Department of Surgery, Veterans Administration Medical Center San Francisco, San Francisco, USA
    J Urol 177:113-7. 2007
    ..We examined the outcomes of radical prostatectomy alone in high risk patients with prostate cancer and evaluated changes in high risk prostate cancer outcomes with time...
  76. pmc Do racial differences in prostate size explain higher serum prostate-specific antigen concentrations among black men?
    John C Mavropoulos
    Department of Pathology, Duke University School of Medicine, Durham, North Carolina 27710, USA
    Urology 69:1138-42. 2007
    ..To determine whether elevated serum prostate-specific antigen (PSA) values in black men are due, at least partially, to larger prostate size among black men...
  77. ncbi request reprint Prostate cancer early detection. Clinical practice guidelines in oncology
    Mark H Kawachi
    J Natl Compr Canc Netw 5:714-36. 2007